Quality - safety and efficacy studies of medicines

EMA seeks to procure the services of research organisations to perform pre- and post-authorisation studies on the quality - safety and efficacy of human and veterinary medicines - generating complementary evidence to support regulatory decision-making. The scope of research covers both nationally and centrally authorised medicinal products - as well as non-product related topics. Studies may concern research under 7 Lots: Lot 1 translational research; Lot 2 veterinary research; Lot 3 methodological/statistical research; Lot 4 qualitative research; Lot 5 pharmacoepidemiological research; Lot 6 innovative technologies; Lot 7 computational methods for comparison of molecular structural features in the context of medicines for rare diseases. ECDC is also participating as a contracting authority only with respect to Lot 5 pharmacoepidemiological research. Het EMA probeert onderzoeksinstellingen...